COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica signe un accord pour acquérir le groupe Espansione et accélérer ainsi sa croissance dans le domaine de la med-tech

16/12/2024 - 18:00

EssilorLuxottica signe un accord pour acquérir le groupe Espansione et accélérer ainsi sa croissance dans le domaine de la med-tech EssilorLuxottica renforce son portefeuille d’instruments perfectionnés de santé [...]

Smith+Nephew expands AETOS™ Shoulder System with new stemless option for anatomic shoulder arthroplasty

16/12/2024 - 16:00

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance from the United States Food & Drug Administration for a stemless anatomic total shoulder for [...]

Journal of Clinical Oncology Publishes NXC-201 Positive Clinical Results in relapsed/refractory AL Amyloidosis

16/12/2024 - 15:48

Chimeric antigen receptor T-cell (CAR-T) cell therapy NXC-201 is a novel approach to treat relapsed/refractory AL Amyloidosis NXC-201 demonstrated compelling clinical activity, rapid and deep complete responses in frail [...]

HWH International Inc. announces a collaboration with Asia Business College to launch the Hapi Wealth Program in China in the 1st quarter of 2025.

16/12/2024 - 15:20

BETHESDA, MD, Dec. 16, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. (“HWH” or the “Company”) (Nasdaq: HWH) is pleased to announce a strategic partnership with Asia Business College to launch its Hapi Wealth program [...]

Healthcare Integrated Technologies, Inc. Welcomes Tim Brady as its Full-Time Chief Financial Officer

16/12/2024 - 15:15

Knoxville, Tennessee, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies, Inc. (“HiTC”), a leading innovator in healthcare solutions, is proud to announce the December 1, 2024 appointment of Timothy [...]

Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer

16/12/2024 - 15:05

BOSTON and LONDON, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX) today announced the appointment of Torsten Hombeck, Ph.D. as Chief Financial Officer, effective December 16, 2024. Dr. Hombeck [...]

Epilepsy Foundation Elevates Leadership Team: Dr. Caitlin Grzeskowiak Named Chief Research and Innovation Officer, Dr. Jacqueline French Appointed Medical Director

16/12/2024 - 15:00

Grzeskowiak and French set to advance research and medical care for the epilepsy community through innovation and collaboration BOWIE, Md., Dec. 16, 2024 (GLOBE NEWSWIRE) -- The Epilepsy Foundation of America is proud [...]

T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.

16/12/2024 - 15:00

LEXINGTON, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that its multi-year [...]

JenaValve Announces First Case for Inclusion in JENA-VAD Registry

16/12/2024 - 15:00

Registry seeks to evaluate the safety and effectiveness of the JenaValve Trilogy™ Heart Valve System in patients with left ventricular assist devices (LVADs) and clinically significant aortic regurgitation IRVINE, Calif [...]

Scilex Holding Company Announces Early Installment Payment on its Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation

16/12/2024 - 15:00

PALO ALTO, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing the [...]

invIOs to present progress across oncology pipeline during JP Morgan Week 2025

16/12/2024 - 15:00

VIENNA, Dec. 16, 2024 (GLOBE NEWSWIRE) -- invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, will be participating in JP Morgan week activities in San Francisco, [...]

Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format

16/12/2024 - 14:37

The term sheet is non-binding, subject to the execution of a definitive agreement Vancouver, Canada, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), [...]

Nova Leap Health Corp. announces Closing of Strategic Acquisition in Florida

16/12/2024 - 14:33

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Dec. 16, 2024 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or “the Company”), a [...]

BioSyent Announces Renewal of Normal Course Issuer Bid

16/12/2024 - 14:30

MISSISSAUGA, Ontario, Dec. 16, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has accepted the Company’s Notice of [...]

Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant

16/12/2024 - 14:30

PONTE VEDRA, Fla., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]

Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference

16/12/2024 - 14:30

CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]

New InsiGHTS Trial of TransCon™ hGH (Lonapegsomatropin) in Turner Syndrome Achieved Primary Objective at Week 26

16/12/2024 - 14:30

- Results for all three TransCon hGH starting dose cohorts, in first clinical trial of an indication outside of growth hormone deficiency, showed a safety and tolerability profile comparable to daily somatropin - [...]

Allogene Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

16/12/2024 - 14:30

SOUTH SAN FRANCISCO, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for [...]

Oragenics, Inc. Announces Conversion of Preferred Shares and Elimination of Liquidation Preference

16/12/2024 - 14:09

SARASOTA, Fla., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE: OGEN), a biotechnology company advancing innovative treatments for brain-related health conditions, today announced the conversion of its [...]